MARL, Germany
,
October 31, 2022
(press release)
–
With the new myFLEXINO® digital portal, Evonik is expanding and centralizing its service offering for plasticizer customers. myFLEXINO® will become the first digital point of contact for customers to make interaction with Evonik as convenient and efficient as possible. All technical content and documents are accessible in one place. The platform brings together existing application engineering expertise and enables customers to find answers to their questions, and to get in touch with plasticizer experts from Evonik - whether it's for formulation support, regulatory issues, or a sample order. The launch of the myFLEXINO® platform is an important milestone in the digitization strategy of Evonik's Performance Intermediates business line. "The implementation of a digital service offering promotes technical interaction with our customers and thus supports the continued strategic development of our plasticizers business," says Roland Pietz, head of market segment Oxo Alcohols and Plasticizers. "We want to make it as convenient as possible for our business partners to contact us and to find relevant information. In addition, this is how we are transferring our technical service for application technology to the digital world," adds Dr. Melike Bayram, head of technical customer support for plasticizers. Based on customer feedback, the platform will then be continuously updated with new content. The formulation assistant and the virtual laboratory offer particular added value for customers. The formulation assistant allows the customer to virtually simulate different formulations with just a few clicks. The technical data generated in the process help to assess the performance of various plasticizers in the selected formulation. Time-consuming laboratory tests are thus reduced. In the virtual lab, platform users can explore for themselves step-by-step which equipment is typically used in the development of new plasticizers. Using videos and short brochures, it is possible to see in detail how researchers at Evonik work. This insight allows customers to take part in the development process themselves and learn about Evonik's measurement methods. In addition, myFLEXINO® offers the possibility to view current webinars and the latest presentations from events. Technical data sheets and safety data sheets, as well as many other documents are also available. Evonik's portfolio includes the plasticizers VESTINOL® 9 (DINP), ELATUR® CH (DINCH), ELATUR® DPT and the latest product ELATUR® DINCD. Information about all these products is available on the platform. Evonik is one of the world leaders in specialty chemicals. The company is active in more than 100 countries around the world and generated sales of €15 billion and an operating profit (adjusted EBITDA) of €2.38 billion in 2021. Evonik goes far beyond chemistry to create innovative, profitable and sustainable solutions for customers. About 33,000 employees work together for a common purpose: We want to improve life today and tomorrow. The forever young classics of the Performance Materials Division stand for products and technologies that are continuously improved. They are the basis for many modern applications, for example in the areas of mobility, nutrition, pharmaceuticals or plastics. The divisions portfolio generated sales of €2.91 billion in 2021 with about 1,600 employees. In so far as forecasts or expectations are expressed in this press release or where our statements concern the future, these forecasts, expectations or statements may involve known or unknown risks and uncertainties. Actual results or developments may vary, depending on changes in the operating environment. Neither Evonik Industries AG nor its group companies assume an obligation to update the forecasts, expectations or statements contained in this release.
* All content is copyrighted by Industry Intelligence, or the original respective author or source. You may not recirculate, redistrubte or publish the analysis and presentation included in the service without Industry Intelligence's prior written consent. Please review our terms of use.
